{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "64c55335-775c-4df1-84b4-e25638452c64", "code": "1886-26-6", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=1886-26-6", "code_system": "CAS", "references": [ "a75e16f7-3678-466e-a301-6b7f7590e27c", "a1ab819b-b0c2-47fd-918c-d177f18ffa31" ] }, { "uuid": "b9d8c7f6-3dcc-49c6-8ebd-3e74344ae0e0", "code": "15897", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/15897", "code_system": "PUBCHEM", "references": [ "a75e16f7-3678-466e-a301-6b7f7590e27c" ] }, { "uuid": "fe095515-1696-8f89-214b-5d52541883e1", "code": "Norfenfluramine", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Norfenfluramine", "code_system": "WIKIPEDIA", "references": [ "a4679ad3-e9d3-8a13-8867-532f099514ec" ] }, { "uuid": "f6533d46-6838-4b86-90ff-dda6b87ab11e", "code": "037A9J3PSW", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "a7369046-29a4-9855-8e1d-c6f67fd27ec6", "code": "43036", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=43036", "code_system": "NSC", "references": [ "cf30a154-4e3b-ec9f-f025-4ef76ddafacd" ] }, { "uuid": "a9300ec9-9fb4-48d0-1965-dafb37ad629c", "code": "DTXSID60904717", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID60904717", "code_system": "EPA CompTox" } ], "substance_class": "chemical", "references": [ { "uuid": "f429f8f3-337d-4d32-89ab-117ba77cd3cd", "citation": "SCIFINDER", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "4962201d-0dec-4ea7-b10e-3476eab90b19", "citation": "STN (SCIFINDER)", "doc_type": "STN (SCIFINDER)", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a8078f78-11ed-4177-a965-d5081bba34c7", "citation": "CHEMID", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "59fa05f2-e870-4b42-bebd-50e8bd90bd86", "citation": "STN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a75e16f7-3678-466e-a301-6b7f7590e27c", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493392572000, "tags": [ "NOMEN" ] }, { "uuid": "5f933dd4-ecbe-448f-b879-cd57f59f4db9", "citation": "SRS import [037A9J3PSW]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=037A9J3PSW", "doc_type": "SRS", "public_domain": true, "document_date": 1493392572000, "tags": [ "NOMEN" ] }, { "uuid": "eea1420f-6d23-4b2a-85ff-c1093db82d37", "citation": "wik", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "a4679ad3-e9d3-8a13-8867-532f099514ec", "citation": "WIKI", "url": "https://en.wikipedia.org/wiki/Norfenfluramine", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "a1ab819b-b0c2-47fd-918c-d177f18ffa31", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "d9991a21-efc8-4817-a253-40fa29b9be3f", "citation": "wik", "doc_type": "WIKI", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "cf30a154-4e3b-ec9f-f025-4ef76ddafacd", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "11d31102-db55-4a79-94f9-b48a8a2d6dc9", "citation": "Andrejak, Michel, and Christophe Tribouilloy. \"Drug-induced valvular heart disease: an update.\" Archives of Cardiovascular Diseases 106.5 (2013): 333-339.", "url": "https://www.sciencedirect.com/science/article/pii/S187521361300034X", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "1f1e17d7-85c8-4359-9b07-01bc44421943", "citation": "Andrejak, Michel, and Christophe Tribouilloy. \"Drug-induced valvular heart disease: an update.\" Archives of Cardiovascular Diseases 106.5 (2013): 333-339.", "url": "https://www.sciencedirect.com/science/article/pii/S187521361300034X", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "219b8bd8-7c48-4e53-bb9f-9bf70b19d985", "id": "219b8bd8-7c48-4e53-bb9f-9bf70b19d985", "molfile": "\n Marvin 01132101542D \n\n 14 14 0 0 0 0 999 V2000\n 1.5317 0.0069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.5283 0.8314 0.0000 C 0 0 0 0 0 0 0 0 0 3 0 0\n 2.2424 1.2454 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 0.8176 1.2419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.1034 0.8280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -0.6106 1.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -1.3247 0.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -1.3247 -0.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -0.6106 -0.4174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.1069 -0.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -0.6106 -1.2419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -1.4385 -1.2384 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0\n 0.2104 -1.2384 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0\n -0.6175 -2.0664 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 1 0 0 0 0\n 2 3 1 0 0 0 0\n 4 2 1 0 0 0 0\n 5 4 1 0 0 0 0\n 5 6 1 0 0 0 0\n 5 10 2 0 0 0 0\n 6 7 2 0 0 0 0\n 7 8 1 0 0 0 0\n 9 8 2 0 0 0 0\n 10 9 1 0 0 0 0\n 9 11 1 0 0 0 0\n 11 12 1 0 0 0 0\n 11 13 1 0 0 0 0\n 11 14 1 0 0 0 0\nM END", "smiles": "CC(Cc1cccc(c1)C(F)(F)F)N", "formula": "C10H12F3N", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "RACEMIC", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "8ab43534-1c52-40b3-9dac-4a9c36bcb5e7" }, "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "203.2046", "optical_activity": "( + / - )", "stereo_centers": 1 } ], "definition_level": "COMPLETE", "uuid": "1a8941c5-05a3-4922-8ace-2249101efcd9", "version": "14", "structure": { "id": "80ddc1eb-b8e3-4d2f-aec2-3ac2badec3f3", "molfile": "\n Marvin 01132106412D \n\n 14 14 0 0 0 0 999 V2000\n 0.1034 0.8280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.1069 -0.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -0.6106 1.2350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.8176 1.2419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -0.6106 -0.4174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -1.3247 0.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.5283 0.8314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -1.3247 -0.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n -0.6106 -1.2419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.5317 0.0069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.2424 1.2454 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n -1.4385 -1.2384 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0\n 0.2104 -1.2384 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0\n -0.6175 -2.0664 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 0 0 0 0\n 1 3 2 0 0 0 0\n 1 4 1 0 0 0 0\n 2 5 2 0 0 0 0\n 3 6 1 0 0 0 0\n 4 7 1 0 0 0 0\n 5 8 1 0 0 0 0\n 5 9 1 0 0 0 0\n 7 10 1 0 0 0 0\n 7 11 1 0 0 0 0\n 9 12 1 0 0 0 0\n 9 13 1 0 0 0 0\n 9 14 1 0 0 0 0\n 6 8 2 0 0 0 0\nM END", "smiles": "CC(Cc1cccc(c1)C(F)(F)F)N", "formula": "C10H12F3N", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "RACEMIC", "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "203.2046", "optical_activity": "( + / - )", "references": [ "5f933dd4-ecbe-448f-b879-cd57f59f4db9", "a8078f78-11ed-4177-a965-d5081bba34c7" ], "stereo_centers": 1 }, "unii": "037A9J3PSW", "relationships": [ { "uuid": "bf973a8e-3d3b-4659-aeee-7c84a8d74fa4", "amount": { "uuid": "fb4c0c15-249d-493e-b4db-9df54a59a150" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "64edc1aa-aceb-4b8e-83a2-cf6db8ce909e", "refuuid": "1a8941c5-05a3-4922-8ace-2249101efcd9", "name": "Norfenfluramine", "unii": "037A9J3PSW", "linking_id": "037A9J3PSW", "ref_pname": "Norfenfluramine", "substance_class": "reference" } }, { "uuid": "d1b4ea9b-1e12-4dbe-8c91-3bc5b128d39a", "amount": { "uuid": "ea359640-c622-4501-8f37-56f4d84ce2fc" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "1356b6f8-9053-4354-9e8a-872c7c4029bc", "refuuid": "44314e11-be44-4146-a7d1-932b73fa2b1d", "name": "NORFENFLURAMINE HYDROCHLORIDE", "unii": "3005782T7P", "linking_id": "3005782T7P", "ref_pname": "NORFENFLURAMINE HYDROCHLORIDE", "substance_class": "reference" } }, { "uuid": "77e56e70-eb5b-4aa9-9201-2d333e4f2c56", "amount": { "uuid": "99fc9925-fed0-4f93-9515-29f055c8da6a" }, "type": "ENANTIOMER->RACEMATE", "related_substance": { "uuid": "f1448822-5c2c-4de0-ba1e-9736f691bfda", "refuuid": "a5ed21ba-17fc-456b-9411-20620c05cec2", "name": "NORDEXFENFLURAMINE", "unii": "CLX07A6ZIY", "linking_id": "CLX07A6ZIY", "ref_pname": "NORDEXFENFLURAMINE", "substance_class": "reference" } }, { "uuid": "339edd5a-9680-4a13-939f-c8429619bf98", "amount": { "uuid": "42508a34-68b5-45ee-a352-be95de93a72c" }, "type": "ENANTIOMER->RACEMATE", "related_substance": { "uuid": "26aa955c-5e4f-41b8-a126-bfbb2f772867", "refuuid": "c225f705-35fc-41e8-9055-ba2dbfa6cfbc", "name": "NORFENFLURAMINE, (R)-", "unii": "ODG984O60W", "linking_id": "ODG984O60W", "ref_pname": "NORFENFLURAMINE, (R)-", "substance_class": "reference" } }, { "uuid": "af8f3564-77df-453a-84fb-c373dc0ff273", "amount": { "uuid": "1edc5cd4-5c18-41be-a138-a736ec6dbae8", "average": 44, "high": 65, "low": 27, "units": "NANOMOLAR" }, "comments": "We propose that preferential stimulation of valvular 5-HT2B receptors by norfenfluramine, ergot drugs, or 5-HT released from carcinoid tumors (with\nor without accompanying 5-HT2A receptor activation) may contribute to valvular fibroplasia in humans.", "qualification": "Ki", "type": "OFF-TARGET->AGONIST", "related_substance": { "uuid": "b1569627-514a-43b2-89ba-072a29109eb2", "refuuid": "16a75fdf-b595-4436-b1de-1d9e821d264a", "name": "5-HYDROXYTRYPTAMINE RECEPTOR 2B", "unii": "6E2Z4UWILI", "linking_id": "6E2Z4UWILI", "ref_pname": "5-HYDROXYTRYPTAMINE RECEPTOR 2B", "substance_class": "reference" } }, { "uuid": "858d091a-f623-4fbd-afb6-251be7a728a5", "amount": { "uuid": "c0fe34f8-9751-49e5-9ab3-eac0970e0b08" }, "comments": "Responsible for ", "type": "PARENT->METABOLITE TOXIC", "interaction_type": "MAJOR", "related_substance": { "uuid": "6af10d75-f611-4aeb-b336-af1c2982dbd7", "refuuid": "76960c91-ffbc-40cd-a862-8a3a858209fd", "name": "FENFLURAMINE", "unii": "2DS058H2CF", "linking_id": "2DS058H2CF", "ref_pname": "FENFLURAMINE", "substance_class": "reference" } }, { "uuid": "2c722717-b00a-40e1-a0f2-0da3c2f8f005", "amount": { "uuid": "374b086b-15d3-404b-b9e1-de665b7f8222" }, "comments": "Preferential stimulation of valvular 5-HT2B receptors by norfenfluramine, ergot drugs, or 5-HT released from carcinoid tumors (with or without accompanying 5-HT2A receptor activation) may contribute to valvular fibroplasia in humans.", "type": "PARENT->METABOLITE TOXIC", "references": [ "1f1e17d7-85c8-4359-9b07-01bc44421943" ], "related_substance": { "uuid": "a98cfbc5-f7ea-4832-9ae8-42fb4aeed6de", "refuuid": "eff235da-0aba-4a40-9f1d-1a66fb2009c0", "name": "BENFLUOREX", "unii": "403FO0NQG3", "linking_id": "403FO0NQG3", "ref_pname": "BENFLUOREX", "substance_class": "reference" } } ], "names": [ { "uuid": "7bb8003f-635f-43ef-97a6-cad242b39aba", "name": "(±)-2-AMINO-1-(3'-TRIFLUOROMETHYLPHENYL)PROPANE", "stdName": "(+/-)-2-AMINO-1-(3'-TRIFLUOROMETHYLPHENYL)PROPANE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f429f8f3-337d-4d32-89ab-117ba77cd3cd", "4962201d-0dec-4ea7-b10e-3476eab90b19" ], "display_name": false }, { "uuid": "d0cd0fb0-7fc9-4fc8-8b7d-99e4a4aa234e", "name": "(±)-NORFENFLURAMINE", "stdName": "(+/-)-NORFENFLURAMINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "4962201d-0dec-4ea7-b10e-3476eab90b19", "59fa05f2-e870-4b42-bebd-50e8bd90bd86" ], "display_name": false }, { "uuid": "ed04b55b-9643-48e9-844d-746f18446f03", "name": ".ALPHA.-METHYL-3-(TRIFLUOROMETHYL)BENZENEETHANAMINE", "stdName": ".ALPHA.-METHYL-3-(TRIFLUOROMETHYL)BENZENEETHANAMINE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "f429f8f3-337d-4d32-89ab-117ba77cd3cd", "4962201d-0dec-4ea7-b10e-3476eab90b19" ], "display_name": false }, { "uuid": "f5d06fb2-3b1a-43a2-9207-dd35de014d71", "name": "1-(M-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE", "stdName": "1-(M-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "4962201d-0dec-4ea7-b10e-3476eab90b19", "59fa05f2-e870-4b42-bebd-50e8bd90bd86" ], "display_name": false }, { "uuid": "47ccc965-65a8-4ef2-9e77-aeb329449674", "name": "2-AMINO-1-(3-(TRIFLUOROMETHYL)PHENYL)PROPANE", "stdName": "2-AMINO-1-(3-(TRIFLUOROMETHYL)PHENYL)PROPANE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "4962201d-0dec-4ea7-b10e-3476eab90b19", "59fa05f2-e870-4b42-bebd-50e8bd90bd86" ], "display_name": false }, { "uuid": "415de997-304a-4376-a6e0-94540ec525ec", "name": "BENZENEETHANAMINE, .ALPHA.-METHYL-3-(TRIFLUOROMETHYL)-", "stdName": "BENZENEETHANAMINE, .ALPHA.-METHYL-3-(TRIFLUOROMETHYL)-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "f429f8f3-337d-4d32-89ab-117ba77cd3cd", "4962201d-0dec-4ea7-b10e-3476eab90b19" ], "display_name": false }, { "uuid": "4ca53320-3c11-4f83-9879-4f68140453c0", "name": "DESETHYLFENFLURAMINE", "stdName": "DESETHYLFENFLURAMINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "4962201d-0dec-4ea7-b10e-3476eab90b19", "59fa05f2-e870-4b42-bebd-50e8bd90bd86" ], "display_name": false }, { "uuid": "196e4393-fedd-43c0-843d-35a2f5ef2cea", "name": "DL-NORFENFLURAMINE", "stdName": "DL-NORFENFLURAMINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f429f8f3-337d-4d32-89ab-117ba77cd3cd", "4962201d-0dec-4ea7-b10e-3476eab90b19" ], "display_name": false }, { "uuid": "0de8a48a-6352-450a-a15d-b3a2bb0e5f71", "name": "JP-92", "stdName": "JP-92", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "4962201d-0dec-4ea7-b10e-3476eab90b19", "59fa05f2-e870-4b42-bebd-50e8bd90bd86" ], "display_name": false }, { "uuid": "2ee83971-448b-4d3c-aca1-0bc88a9a13a0", "name": "NSC-43036", "stdName": "NSC-43036", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "f429f8f3-337d-4d32-89ab-117ba77cd3cd", "4962201d-0dec-4ea7-b10e-3476eab90b19" ], "display_name": false }, { "uuid": "7ead2ad5-656a-441e-904a-552ab435c5f6", "name": "Norfenfluramine", "stdName": "NORFENFLURAMINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a8078f78-11ed-4177-a965-d5081bba34c7", "4962201d-0dec-4ea7-b10e-3476eab90b19" ], "display_name": true } ], "properties": [ { "uuid": "d4d01dbe-3e98-411e-9e58-17a6f40a4b5d", "name": "Biological Half-life", "value": { "uuid": "5959787f-0b13-445b-a7cc-c20692c59f9e", "average": 34, "units": "hours", "non_numeric_value": "FORMS FROM FENFLURAMINE" }, "defining": false, "property_type": "PHARMACOKINETIC" } ] } ] }